Phone: 1.510.856.5600|info@anthera.com

Press Releases

 
Press Releases
  Date Title and Summary View
Sep 6, 2006
San Francisco‚ CA – September 6‚ 2006 Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that it has entered into a license agreement with Eli Lilly and Company and Shionogi & Co., Ltd. under which Anthera has obtained worldwide (except ...
Nov 17, 2005
San Francisco‚ CA – November 17‚ 2005 – Anthera Pharmaceuticals‚ Inc‚ a private start–up pharmaceutical company committed to addressing the unmet medical needs of patients with life–threatening inflammatory diseases‚ announced that David E. Thompson has been appointed to the Co...
Apr 20, 2005
San Francisco‚ CA – April 20‚ 2005 – Anthera Pharmaceuticals‚ Inc‚ a private start–up pharmaceutical company specializing in serious respiratory and inflammatory diseases‚ today announced it has completed its Series A Preferred financing and is moving forward under a proven leadership ...
Page: FirstPrevious ...
19
= add release to Briefcase
Print Friendly